Frequently asked questions

Noricum Biosoft builds agentic AI systems for biotech and biopharma and collaborates as a contractor on custom engagements. Its products are Helix.AI, an autonomous bioinformatics agent, and DataWeaver.AI, an AI co-pilot for scientific data management.

Yes. Noricum Biosoft takes on collaborative engagements to design and build custom agentic AI systems for biotech, biopharma, digital health, and adjacent science-heavy domains. Engagements follow Discover → Test → Play, and customized work is the collaborator's intellectual property. See noricum-biosoft.com/collaborate.

Both. Helix.AI and DataWeaver.AI are open-source products. When a team's workflow needs customization on top of that foundation, Noricum Biosoft collaborates as an embedded partner — not a black-box vendor — and the collaborator owns the resulting IP.

Typical collaborations include custom bioinformatics and analysis agents built on Helix.AI, data-integration and quality systems built on DataWeaver.AI, digital-health decision support, and applied agentic AI products for science-heavy workflows. Engagements start with a short Discover phase.

Agentic AI for bioinformatics describes AI systems that do more than generate code — they plan an analysis, wait for human approval, then generate code, choose infrastructure, and execute it end to end while preserving provenance and reproducibility.

General assistants generate code that you run yourself. Helix.AI proposes a plan, runs the code in a sandbox after you approve it, chooses the right infrastructure per run, and produces reproducible artifacts — a standalone script plus a bundle with plots, tables, and full history.

No. Helix.AI proposes a plan in plain language and nothing executes until you explicitly confirm it. The plan also persists across sessions.

Bulk RNA-seq, variant calling, single-cell RNA-seq, quality control, alignment, enrichment, and custom tabular or scientific analyses. If no built-in tool fits, it can generate a new one on demand.

Common biological and tabular formats including CSV, Excel, FASTQ, FASTA, BAM/SAM, VCF, and H5AD — profiled at upload time.

Every run produces a standalone analysis script plus a bundle containing the script, plots, tables, and full history. Iterative changes patch the script and re-run, and each run links to its parent.

Helix.AI routes each run to the most appropriate environment — a local sandbox or scaled cloud infrastructure — based on data size and cost.

It is designed with a human-approval gate, defensible provenance, and auditable, repeatable outputs — characteristics that matter in regulated, high-stakes science.

Helix.AI is in private beta. Use any "Request beta access" button to open our contact form (pre-filled for a beta request), and the team — which is selectively onboarding biotech and biopharma teams — will be in touch.

Yes. Helix.AI is open source under the MIT license, and Noricum Biosoft's data-management co-pilot DataWeaver.AI is open source under AGPL-3.0. Both are available on GitHub at github.com/Noricum-BioSoft.

Our software products are open source at their cores. When customization is needed, we build it collaboratively on that foundation — and the customized software solutions are the intellectual property of the collaborator. You own what we tailor to your science, workflows, and data.